ClinicalTrials.Veeva

Menu

Triglyceride-Glucose Index in Diabetic Nephropathy in Type 2diaberes Mellitus Patients

A

Assiut University

Status

Not yet enrolling

Conditions

Diabetes Mellitus, Type 2

Study type

Observational

Funder types

Other

Identifiers

NCT05602532
TYG index in DN in type 2 DM

Details and patient eligibility

About

The aim of the present study is to investigate the associations between the TyG index and diabetic nephropathy in patients with type2 DM .

Full description

the triglyceride-glucose (TyG) index was proposed as a simple and reliable surrogate marker of IR, and it has been reported to be closely correlated with the HOMA-IR index. The TyG index has the advantage of being applicable in clinical practice since both triglyceride and glucose levels are routinely measured and the cost of these measurements is low.

Enrollment

100 estimated patients

Sex

All

Ages

25 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with type 2 DM

Exclusion criteria

  • (1) Individuals with obstructive uropathy, severe heart failure, stroke, liver disease, cancer, autoimmune disease (2) Pregnant woman. (3)End stage renal disease patients on dialysis ( glomerular filtration rate <15 mL/min/1.73 m2) or renal transplantation.

(4) Type 1 Diabetic patient. (5) Albuminuria due to non-diabetic renal disease

Trial contacts and locations

0

Loading...

Central trial contact

Aya Abo Eyosr Garhey; Salah Abdelazeem Argoon

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems